136 related articles for article (PubMed ID: 38374738)
1. Impact of Differential Rates of Disease Progression in Amyloid-Positive Early Alzheimer's Disease: Findings from a Longitudinal Cohort Analysis.
Chandler J; Georgieva M; Desai U; Done N; Gomez-Lievano A; Ye W; Zhao A; Eid D; Hilts A; Kirson N; Schilling T
J Prev Alzheimers Dis; 2024; 11(2):320-328. PubMed ID: 38374738
[TBL] [Abstract][Full Text] [Related]
2. Potential Implications of Slowing Disease Progression in Amyloid-Positive Early Alzheimer's Disease: Estimates from Real-World Data.
Chandler J; Done N; Desai U; Georgieva M; Gomez-Lievano A; Ye W; Zhao A; Eid D; Hilts A; Kirson N; Schilling T
J Prev Alzheimers Dis; 2024; 11(2):310-319. PubMed ID: 38374737
[TBL] [Abstract][Full Text] [Related]
3. Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data Set.
Puzo C; Labriola C; Sugarman MA; Tripodis Y; Martin B; Palmisano JN; Steinberg EG; Stein TD; Kowall NW; McKee AC; Mez J; Killiany RJ; Stern RA; Alosco ML
Alzheimers Res Ther; 2019 Jul; 11(1):64. PubMed ID: 31351489
[TBL] [Abstract][Full Text] [Related]
4. Informant characteristics are associated with the Clinical Dementia Rating Sum of Boxes scores in the Alzheimer's Disease patients participating in the National Alzheimer's Coordinating Center Uniform Data Set.
Vargas-Gonzalez JC; Chadha AS; Castro-Aldrete L; Ferretti MT; Tartaglia C
Res Sq; 2024 Mar; ():. PubMed ID: 38559129
[TBL] [Abstract][Full Text] [Related]
5. Psychotropic Medication and Cognitive, Functional, and Neuropsychiatric Outcomes in Alzheimer's Disease (AD).
Oh ES; Rosenberg PB; Rattinger GB; Stuart EA; Lyketsos CG; Leoutsakos JS
J Am Geriatr Soc; 2021 Apr; 69(4):955-963. PubMed ID: 33382921
[TBL] [Abstract][Full Text] [Related]
6. Cognitive trajectory in mild cognitive impairment due to primary age-related tauopathy.
Teylan M; Mock C; Gauthreaux K; Chen YC; Chan KCG; Hassenstab J; Besser LM; Kukull WA; Crary JF
Brain; 2020 Feb; 143(2):611-621. PubMed ID: 31942622
[TBL] [Abstract][Full Text] [Related]
7. Classification, Prediction, and Concordance of Cognitive and Functional Progression in Patients with Mild Cognitive Impairment in the United States: A Latent Class Analysis.
Mouchet J; Betts KA; Georgieva MV; Ionescu-Ittu R; Butler LM; Teitsma X; Delmar P; Kulalert T; Zhu J; Lema N; Desai U
J Alzheimers Dis; 2021; 82(4):1667-1682. PubMed ID: 34219723
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal Neuropsychological Outcome in Taiwanese Alzheimer's Disease Patients Treated with Medication.
Yang YH; Wu MN; Chou PS; Su HC; Lin SH; Sung PS
Curr Alzheimer Res; 2018 Mar; 15(5):474-481. PubMed ID: 29032750
[TBL] [Abstract][Full Text] [Related]
9. Initial non-amnestic symptoms relate to faster rate of functional and cognitive decline compared to amnestic symptoms in neuropathologically confirmed dementias.
Pillai JA; Bena J; Maly EF; Leverenz JB
Alzheimers Dement; 2023 Jul; 19(7):2956-2965. PubMed ID: 36648159
[TBL] [Abstract][Full Text] [Related]
10. Cholinesterase Inhibitors May Not Benefit Mild Cognitive Impairment and Mild Alzheimer Disease Dementia.
Han JY; Besser LM; Xiong C; Kukull WA; Morris JC
Alzheimer Dis Assoc Disord; 2019; 33(2):87-94. PubMed ID: 30633043
[TBL] [Abstract][Full Text] [Related]
11. Comparing measures of decline to dementia in amnestic MCI subjects in the National Alzheimer's Coordinating Center (NACC) Uniform Data Set.
Monsell SE; Liu D; Weintraub S; Kukull WA
Int Psychogeriatr; 2012 Oct; 24(10):1553-60. PubMed ID: 22717299
[TBL] [Abstract][Full Text] [Related]
12. Variants in PPP3R1 and MAPT are associated with more rapid functional decline in Alzheimer's disease: the Cache County Dementia Progression Study.
Peterson D; Munger C; Crowley J; Corcoran C; Cruchaga C; Goate AM; Norton MC; Green RC; Munger RG; Breitner JC; Welsh-Bohmer KA; Lyketsos C; Tschanz J; Kauwe JS;
Alzheimers Dement; 2014 May; 10(3):366-71. PubMed ID: 23727081
[TBL] [Abstract][Full Text] [Related]
13. Relationships of change in Clinical Dementia Rating (CDR) on patient outcomes and probability of progression: observational analysis.
Tariot PN; Boada M; Lanctôt KL; Hahn-Pedersen J; Dabbous F; Udayachalerm S; Raket LL; Halchenko Y; Michalak W; Weidner W; Cummings J
Alzheimers Res Ther; 2024 Feb; 16(1):36. PubMed ID: 38355706
[TBL] [Abstract][Full Text] [Related]
14. Cohort Effects in Progression Rate on Cognitive and Functional Measures in an Alzheimer's Disease Clinical Cohort.
Pavlik VN; Chan W; Darby E
J Alzheimers Dis; 2019; 71(2):659-669. PubMed ID: 31424408
[TBL] [Abstract][Full Text] [Related]
15. Disease Progression and Longitudinal Clinical Outcomes of Lewy Body Dementia in the NACC Database.
Chandler J; Georgieva M; Desai U; Kirson N; Lane H; Cheung HC; Westermeyer B; Biglan K
Neurol Ther; 2023 Feb; 12(1):177-195. PubMed ID: 36378462
[TBL] [Abstract][Full Text] [Related]
16. Metabolic syndrome biomarkers relate to rate of cognitive decline in MCI and dementia stages of Alzheimer's disease.
Pillai JA; Bena J; Bekris L; Kodur N; Kasumov T; Leverenz JB; Kashyap SR;
Alzheimers Res Ther; 2023 Mar; 15(1):54. PubMed ID: 36927447
[TBL] [Abstract][Full Text] [Related]
17. Progression of cognitive, functional, and neuropsychiatric symptom domains in a population cohort with Alzheimer dementia: the Cache County Dementia Progression study.
Tschanz JT; Corcoran CD; Schwartz S; Treiber K; Green RC; Norton MC; Mielke MM; Piercy K; Steinberg M; Rabins PV; Leoutsakos JM; Welsh-Bohmer KA; Breitner JC; Lyketsos CG
Am J Geriatr Psychiatry; 2011 Jun; 19(6):532-42. PubMed ID: 21606896
[TBL] [Abstract][Full Text] [Related]
18. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
[TBL] [Abstract][Full Text] [Related]
19. Mild cognitive impairment in Parkinson's disease versus Alzheimer's disease.
Besser LM; Litvan I; Monsell SE; Mock C; Weintraub S; Zhou XH; Kukull W
Parkinsonism Relat Disord; 2016 Jun; 27():54-60. PubMed ID: 27089852
[TBL] [Abstract][Full Text] [Related]
20. Disease severity and mortality in Alzheimer's disease: an analysis using the U.S. National Alzheimer's Coordinating Center Uniform Data Set.
Crowell V; Reyes A; Zhou SQ; Vassilaki M; Gsteiger S; Gustavsson A
BMC Neurol; 2023 Aug; 23(1):302. PubMed ID: 37580727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
